Editorial: chronic hepatitis C with metabolic dysfunction-associated fatty liver disease — a model for adoption of Sustainable Development Goal 3

Oyekoya Ayonrinde; Richard Goodheart

doi:10.1111/apt.17270

Editorial: chronic hepatitis C with metabolic dysfunction-associated fatty liver disease — a model for adoption of Sustainable Development Goal 3

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	270-271
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	57
Issue number	2
Early online date	5 Dec 2022
DOIs	https://doi.org/10.1111/apt.17270
Publication status	Published - Jan 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/apt.17270

Cite this

@article{1f4a86c541f84220898098b305e7bc5a,

title = "Editorial: chronic hepatitis C with metabolic dysfunction-associated fatty liver disease — a model for adoption of Sustainable Development Goal 3",

keywords = "Hepatitis C virus, Hepatic steatosis, Fatty liver, Non-alcoholic fatty liver disease (NAFLD), Metabolic dysfunction-associated fatty liver disease, Cardiometabolic disease",

author = "Oyekoya Ayonrinde and Richard Goodheart",

year = "2023",

month = jan,

doi = "10.1111/apt.17270",

language = "English",

volume = "57",

pages = "270--271",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Editorial

T2 - chronic hepatitis C with metabolic dysfunction-associated fatty liver disease — a model for adoption of Sustainable Development Goal 3

AU - Ayonrinde, Oyekoya

AU - Goodheart, Richard

PY - 2023/1

Y1 - 2023/1

KW - Hepatitis C virus

KW - Hepatic steatosis

KW - Fatty liver

KW - Non-alcoholic fatty liver disease (NAFLD)

KW - Metabolic dysfunction-associated fatty liver disease

KW - Cardiometabolic disease

UR - http://www.scopus.com/inward/record.url?scp=85143982257&partnerID=8YFLogxK

U2 - 10.1111/apt.17270

DO - 10.1111/apt.17270

M3 - Editorial

C2 - 36468204

AN - SCOPUS:85143982257

SN - 0269-2813

VL - 57

SP - 270

EP - 271

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 2

ER -

Editorial: chronic hepatitis C with metabolic dysfunction-associated fatty liver disease — a model for adoption of Sustainable Development Goal 3

UN SDGs

Access to Document

Other files and links

Cite this